We are proud to announce that Mediclose has received FDA approval, marking a significant milestone in the development of our innovative surgical technology.
This regulatory approval represent an important step in our mission to bring our novel products to market and provide meaningful value to surgical practice.
Mediclose is a fully integrated suturing solution, designed to optimize trocar-site fascia closure, supporting a fast controlled closure to improve safety and consistency in laparoscopic surgery.
